Free Trial
ETR:RHK

RHÖN-KLINIKUM Aktiengesellschaft (RHK) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
€11.40
€12.20
52-Week Range
N/A
Volume
214 shs
Average Volume
43,281 shs
Market Capitalization
$783.20 million
P/E Ratio
16.57
Dividend Yield
1.21%
Price Target
N/A
RHK stock logo

About RHÖN-KLINIKUM Aktiengesellschaft Stock (ETR:RHK)

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation, ophthalmology, pregnancies and births, accident surgery, dentistry, tumors, neurological conditions, and treatment of thoracic, lung, vascular, nerves and the skeletal system, and heart diseases. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.

RHK Stock News Headlines

Rhön-Klinikum kommt gut durchs Corona-Jahr 2021
The death of Nvidia?
Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming.
RHÖN-KLINIKUM Campus Bad Neustadt ist TAVI-Zentrum
See More Headlines
Receive RHK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RHÖN-KLINIKUM Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Care Facilities
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
18,324
Year Founded
N/A

Profitability

Net Income
$46.53 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.80 billion
Book Value
€19.01 per share

Miscellaneous

Free Float
N/A
Market Cap
$783.20 million
Optionable
Not Optionable
Beta
-0.12
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Dr. Tobias Kaltenbach (Age 64)
    CEO & Chairman of Management Board
    Comp: $507k
  • Dr. Stefan Stranz (Age 47)
    CFO & Member of Management Board
    Comp: $543k
  • Dr. Gunther Karl Weiß M.Sc. (Age 56)
    COO & Member of Management Board
    Comp: $625k
  • Julian Schmitt
    Head of Investor Relations & Treasury
  • Mr. Eugen Münch
    Chief Representative

RHK Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of RHÖN-KLINIKUM Aktiengesellschaft own?

Based on aggregate information from My MarketBeat watchlists, some other companies that RHÖN-KLINIKUM Aktiengesellschaft investors own include Seabridge Gold (SA), iShares Silver Trust (SLV), Walt Disney (DIS), Alamos Gold (AGI), Warriedar Resources (AWV), Bayerische Motoren Werke Aktiengesellschaft (BMW) and Anheuser-Busch InBev SA/NV (BUD).

This page (ETR:RHK) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners